Guo J, Zhang C, Zhao H, Yan Y, Liu Z
Genes Dis. 2024; 11(4):101119.
PMID: 38523672
PMC: 10958065.
DOI: 10.1016/j.gendis.2023.101119.
Denton J, Delpire E
Am J Physiol Cell Physiol. 2023; 324(3):C603-C605.
PMID: 36689674
PMC: 9942886.
DOI: 10.1152/ajpcell.00457.2022.
McClenahan S, Kent C, Kharade S, Isaeva E, Williams J, Han C
Mol Pharmacol. 2022; 101(5):357-370.
PMID: 35246480
PMC: 9092466.
DOI: 10.1124/molpharm.121.000464.
Weaver C, Denton J
Am J Physiol Cell Physiol. 2021; 320(6):C1125-C1140.
PMID: 33826405
PMC: 8285633.
DOI: 10.1152/ajpcell.00548.2020.
Marmolejo-Murillo L, Arechiga-Figueroa I, Moreno-Galindo E, Ferrer T, Zamora-Cardenas R, Navarro-Polanco R
J Gen Physiol. 2021; 153(5).
PMID: 33822868
PMC: 8025212.
DOI: 10.1085/jgp.201912540.
A constricted opening in Kir channels does not impede potassium conduction.
Black K, He S, Jin R, Miller D, Bolla J, Clarke O
Nat Commun. 2020; 11(1):3024.
PMID: 32541684
PMC: 7295778.
DOI: 10.1038/s41467-020-16842-0.
Electrophysiological and Pharmacological Characterization of Human Inwardly Rectifying K2.1 Channels on an Automated Patch-Clamp Platform.
Sanson C, Schombert B, Filoche-Romme B, Partiseti M, Bohme G
Assay Drug Dev Technol. 2019; 17(3):89-99.
PMID: 30835490
PMC: 6479253.
DOI: 10.1089/adt.2018.882.
Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992.
Kharade S, Kurata H, Bender A, Blobaum A, Figueroa E, Duran A
Mol Pharmacol. 2018; 94(2):926-937.
PMID: 29895592
PMC: 6041953.
DOI: 10.1124/mol.118.112359.
Beneficial Effects of High Potassium: Contribution of Renal Basolateral K Channels.
Staruschenko A
Hypertension. 2018; 71(6):1015-1022.
PMID: 29712740
PMC: 5945313.
DOI: 10.1161/HYPERTENSIONAHA.118.10267.
Plight of the pore polar bar(rier).
Denton J, Kharade S
Channels (Austin). 2017; 11(6):502-503.
PMID: 28806132
PMC: 5786191.
DOI: 10.1080/19336950.2017.1367234.
Pore Polarity and Charge Determine Differential Block of Kir1.1 and Kir7.1 Potassium Channels by Small-Molecule Inhibitor VU590.
Kharade S, Sheehan J, Figueroa E, Meiler J, Denton J
Mol Pharmacol. 2017; 92(3):338-346.
PMID: 28619748
PMC: 5553192.
DOI: 10.1124/mol.117.108472.
Inhibition of Kir4.1 potassium channels by quinacrine.
Marmolejo-Murillo L, Arechiga-Figueroa I, Cui M, Moreno-Galindo E, Navarro-Polanco R, Sanchez-Chapula J
Brain Res. 2017; 1663:87-94.
PMID: 28288868
PMC: 5502112.
DOI: 10.1016/j.brainres.2017.03.009.
Neural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms.
Kubin L
Compr Physiol. 2016; 6(4):1801-1850.
PMID: 27783860
PMC: 5242202.
DOI: 10.1002/cphy.c160002.
ML418: The First Selective, Sub-Micromolar Pore Blocker of Kir7.1 Potassium Channels.
Swale D, Kurata H, Kharade S, Sheehan J, Raphemot R, Voigtritter K
ACS Chem Neurosci. 2016; 7(7):1013-23.
PMID: 27184474
PMC: 5131535.
DOI: 10.1021/acschemneuro.6b00111.
Computational and functional analyses of a small-molecule binding site in ROMK.
Swale D, Sheehan J, Banerjee S, Husni A, Nguyen T, Meiler J
Biophys J. 2015; 108(5):1094-103.
PMID: 25762321
PMC: 4375722.
DOI: 10.1016/j.bpj.2015.01.022.
G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons.
Ghamari-Langroudi M, Digby G, Sebag J, Millhauser G, Palomino R, Matthews R
Nature. 2015; 520(7545):94-8.
PMID: 25600267
PMC: 4383680.
DOI: 10.1038/nature14051.